Samsung Biologics Co Ltd
KRX:207940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
S-Oil Corp
KRX:010950
|
KR |
|
Star Bulk Carriers Corp
NASDAQ:SBLK
|
GR |
|
Northern Star Resources Ltd
ASX:NST
|
AU |
|
FIRST BANK (Hamilton)
NASDAQ:FRBA
|
US |
|
Grifols SA
MAD:GRF
|
ES |
Wall St Price Targets
Price Targets Summary
Samsung Biologics Co Ltd
According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 2 169 728.0095 KRW with a low forecast of 1 666 500 KRW and a high forecast of 2 421 619.2395 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Samsung Biologics Co Ltd's stock price target?
Price Target
2 169 728.0095
KRW
According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 2 169 728.0095 KRW with a low forecast of 1 666 500 KRW and a high forecast of 2 421 619.2395 KRW.
What is the Revenue forecast for Samsung Biologics Co Ltd?
Projected CAGR
13%
Over the last 11 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 7 years is 13%.
What is the Operating Income forecast for Samsung Biologics Co Ltd?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 7 years is 14%.
What is the Net Income forecast for Samsung Biologics Co Ltd?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 3 years is 12%.
